[Disease burden of lung cancer in the Chinese population, in 1990 and 2013]

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jun;37(6):752-7. doi: 10.3760/cma.j.issn.0254-6450.2016.06.002.
[Article in Chinese]

Abstract

Objective: To analyze the disease burden of lung cancer in the Chinese population, in 1990 and 2013.

Methods: Indicators including mortality rate, years of life lost due to premature mortality (YLL), years lived with disability (YLD), and disability-adjusted of life years (DALY) on lung cancer, were from the results of Global Burden of Disease (GBD) 2013 and were used to describe the burden of disease caused by lung cancer in the Chinese population. Data described the disease burden of lung cancer in China by calculating the changing rates on corresponding parameters in 1990 and 2013.

Results: In China, in 1990 and 2013, the standardized mortality rate of lung cancer increased from 36.04/100 000 to 40.41/100 000 (increased by 12.13%), the standardized YLL rate decreased from 805.07/100 000 to 781.09/100 000 (decreased by 2.98%), the standardized YLD rate increased from 8.57/100 000 to 11.13/100 000 (increased by 29.87%) and the standardized DALY rate decreased from 813.64/100 000 to 792.22/100 000 (decreased by 2.63%). Compared with data in 1990,parameters as the number of deaths, YLL, YLD and DALY of lung cancer all increased, especially in males. Mortality and the DALY rate of lung cancer increased with age in both genders. Mortality and DALY rate were higher in males than those in females in all the age groups. Geographically, standard mortality rate and standard DALY rate in northeast region, north region, southwest region (Sichuan and Chongqing) and part of the east and central regions appeared significantly higher than those in other regions but lower in western region than those in other regions, in 2013.

Conclusions: Burden of disease caused by lung cancer remained serious in China. Provincially,the burden of disease caused by lung cancer appeared different. It is important to strengthen the prevention and control programs that related to lung cancer.

MeSH terms

  • Asian People
  • Female
  • Global Burden of Disease
  • Humans
  • Lung Neoplasms*
  • Male
  • Persons with Disabilities
  • Quality-Adjusted Life Years
  • Reference Standards